MOH — authorised 24 April 2008
- Marketing authorisation holder: SALIX PHARMS
- Status: likely_approved
MOH authorised Relistor on 24 April 2008
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 24 April 2008.
SALIX PHARMS holds the UAE marketing authorisation.